Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Magn Reson Imaging Clin N Am
; 32(2): 233-251, 2024 May.
Article
en En
| MEDLINE
| ID: mdl-38555139
ABSTRACT
For over two centuries, clinicians have been aware of various conditions affecting white matter which had come to be grouped under the umbrella term multiple sclerosis. Within the last 20 years, specific scientific advances have occurred leading to more accurate diagnosis and differentiation of several of these conditions including, neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody disease. This new understanding has been coupled with advances in disease-modifying therapies which must be accurately applied for maximum safety and efficacy.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neuromielitis Óptica
Límite:
Humans
Idioma:
En
Revista:
Magn Reson Imaging Clin N Am
/
Magn. reson. imaging clin. N. Am
/
Magnetic resonance imaging clinics of North America
Asunto de la revista:
DIAGNOSTICO POR IMAGEM
Año:
2024
Tipo del documento:
Article